Evidence map›Paper›PMID 36788987›Full record

ReviewFuture science OA2022

Telemedicine and cancer care in India: promises, opportunities and caveats.

Suryanarayana Vs Deo, Raja Pramanik, Meesha Chaturvedi, Anita Nath, Jaya Ghosh, Saroj Kumar Das Majumdar, Naveen Salins, Geeta Kadayaprath, Pankaj K Garg, Arvind Chaturvedi and 2 more

Abstract readReview
In one paragraph

Review in Future science OA, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed.

  1. Article
  2. Leveraging telemedicine to combat the cancer crisis.Journal of family medicine and primary care · 2025
    Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Review
  10. Review
  11. Review
  12. Review
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Suryanarayana Vs DeoDepartment of Surgical Oncology, Dr. B R Ambedkar Institute-Rotary Cancer Hospital, All India Institute of Medical Sciences (AIIMS), Ansari Nagar, New Delhi, 110029, India.ORCID https://orcid.org/0000-0003-1955-8234
Raja PramanikDepartment of Surgical Oncology, Dr. B R Ambedkar Institute-Rotary Cancer Hospital, All India Institute of Medical Sciences (AIIMS), Ansari Nagar, New Delhi, 110029, India.ORCID https://orcid.org/0000-0003-0483-6254
Meesha ChaturvediICMR- National Centre for Disease Informatics and Research, Bangalore, Karnataka, 562110, India.ORCID https://orcid.org/0000-0003-2169-3099
Anita NathICMR- National Centre for Disease Informatics and Research, Bangalore, Karnataka, 562110, India.ORCID https://orcid.org/0000-0002-9216-6803
Jaya GhoshDepartment of Medical Oncology, Tata Memorial Hospital (TMH), Homi Babha Building, Dr Ernest Borges Rd, Parel East, Parel, Mumbai, Maharashtra, 400012, India.
Saroj Kumar Das MajumdarDepartment of Radiotherapy, All India Institute of Medical Sciences (AIIMS), Patra Pada, Bhubaneswar, Odisha 751019, India.
Naveen SalinsDepartment of Palliative Medicine and Supportive Care, Kasturba Medical College Manipal, Manipal Academy of Higher Education, Manipal, 576104, India.
Geeta KadayaprathDepartment of Surgical Oncology, Max Institute of Cancer Care, Max Super Speciality Hospital, 108A, I.P Extension, Patparganj, New Delhi, 110092, India.
Pankaj K GargDepartment of Surgical Oncology, All India Institute of Medical Sciences (AIIMS), Rishikesh, India.
Arvind ChaturvediDepartment of Radiology, Rajiv Gandhi Cancer Institute, Sector - 5, Rohini Institutional Area, Rohini, New Delhi, 110085, India.
Sandeep MathurDepartment of Surgical Oncology, Dr. B R Ambedkar Institute-Rotary Cancer Hospital, All India Institute of Medical Sciences (AIIMS), Ansari Nagar, New Delhi, 110029, India.
Prashant MathurICMR- National Centre for Disease Informatics and Research, Bangalore, Karnataka, 562110, India.ORCID https://orcid.org/0000-0002-9271-1373

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Telemedicine has revolutionized areas of medical practice and care. It has a potential in field of continuum of cancer care in India. SARS-CoV-2 has highlighted the potential use of this tool effectively. Scope of newer applications of telemedicine in field of cancer is reviewed in current paper enlisting benefits to patient, healthcare providers and centers in a developing country like India. Each of them is supported by appropriate evidence and examples. An analysis of strengths and opportunities when compared with weakness and threats brings out how telemedicine can redistribute oncology work force in a rational way and minimize disruption caused by the pandemic. Telemedicine can be utilized in cancer management starting from prevention, screening, diagnosis, treatment and rehabilitation to palliative care.

Indexed as

Cancer Care continuumoutcomessurvivaltechnologytele-oncology

Identifiers

PMID36788987
PMCPMC9912275

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.